HEADER SURFACE ACTIVE PROTEIN 11-AUG-06 2DWF TITLE NMR STRUCTURE OF MINI-B, AN N-TERMINAL- C-TERMINAL CONSTRUCT FROM TITLE 2 HUMAN SURFACTANT PROTEIN B (SP-B), IN SODIUM DODECYL SULFATE (SDS) TITLE 3 MICELLES COMPND MOL_ID: 1; COMPND 2 MOLECULE: PULMONARY SURFACTANT-ASSOCIATED PROTEIN B; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: MINI-B; COMPND 5 SYNONYM: SP-B, 6 KDA PROTEIN, PULMONARY SURFACTANT-ASSOCIATED COMPND 6 PROTEOLIPID SPLPHE, 18 KDA PULMONARY-SURFACTANT PROTEIN; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 OTHER_DETAILS: THIS SEQUENCE IS A BIOLOGICALLY ACTIVE FRAGMENT OF SOURCE 4 THE PROTEIN SP-B WHICH OCCURS NATURALLY IN HUMANS. KEYWDS MINI-B, SP-B, SURFACTANT PROTEIN B, LIPID ASSOCIATED PROTEIN, SURFACE KEYWDS 2 ACTIVE PROTEIN EXPDTA SOLUTION NMR NUMMDL 15 AUTHOR V.BOOTH,M.SARKER,A.J.WARING,K.M.W.KEOUGH REVDAT 3 09-MAR-22 2DWF 1 REMARK REVDAT 2 24-FEB-09 2DWF 1 VERSN REVDAT 1 03-JUL-07 2DWF 0 JRNL AUTH V.BOOTH,M.SARKER,A.J.WARING,K.M.W.KEOUGH JRNL TITL NMR STRUCTURE OF MINI-B, AN N-TERMINAL - C-TERMINAL JRNL TITL 2 CONSTRUCT FROM HUMAN SURFACTANT PROTEIN B (SP-B), IN SODIUM JRNL TITL 3 DODECYL SULFATE (SDS) MICELLES JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : NMRPIPE 2.2, CNS 1.1 REMARK 3 AUTHORS : DELAGLIO (NMRPIPE), BRUNGER (CNS) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2DWF COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 17-AUG-06. REMARK 100 THE DEPOSITION ID IS D_1000025926. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 318 REMARK 210 PH : 5 REMARK 210 IONIC STRENGTH : 0 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : PARTIALLY 15N-LABELLED PEPTIDE REMARK 210 WITH 15N LABELS ON LEUCINE (3, 7, REMARK 210 22, 25, 29, 31), ALANINE (6, 13) REMARK 210 AND GLYCINE (18); 1.5MM PEPTIDE, REMARK 210 150MM SDS, 0.4MM DSS, 90% H2O, REMARK 210 10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D NOESY; 2D TOCSY; 3D_15N REMARK 210 -SEPARATED_NOESY; 3D_15N- REMARK 210 SEPARATED_TOCSY REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : SPARKY 3.110, MOLMOL 2K.2 REMARK 210 METHOD USED : SIMULATED ANNEALING, MOLECULAR REMARK 210 DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 500 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 15 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 TRP A 2 21.58 -158.01 REMARK 500 1 CYS A 4 -77.78 -49.35 REMARK 500 1 ARG A 5 -37.23 -29.78 REMARK 500 1 LYS A 17 53.22 -108.12 REMARK 500 1 ARG A 20 -80.00 170.04 REMARK 500 1 GLN A 24 -19.81 -47.77 REMARK 500 1 CYS A 33 145.09 -29.07 REMARK 500 2 TRP A 2 12.37 -176.98 REMARK 500 2 ARG A 5 -34.59 -38.01 REMARK 500 2 PRO A 16 -75.95 -64.47 REMARK 500 2 LYS A 17 41.76 -147.64 REMARK 500 2 ARG A 20 -61.31 -107.60 REMARK 500 2 CYS A 33 -161.39 21.20 REMARK 500 3 TRP A 2 11.61 -151.66 REMARK 500 3 CYS A 4 -73.60 -49.24 REMARK 500 3 ARG A 5 -27.68 -38.47 REMARK 500 3 PRO A 16 -70.92 -71.18 REMARK 500 3 LYS A 17 52.02 -144.86 REMARK 500 3 ARG A 20 -76.51 -159.14 REMARK 500 3 CYS A 33 -160.81 34.10 REMARK 500 4 TRP A 2 -27.86 172.51 REMARK 500 4 CYS A 4 -80.77 -43.16 REMARK 500 4 ARG A 5 -37.25 -29.80 REMARK 500 4 ARG A 20 -75.15 177.20 REMARK 500 4 MET A 21 164.63 177.98 REMARK 500 4 CYS A 33 163.88 -35.30 REMARK 500 5 TRP A 2 23.10 -144.62 REMARK 500 5 CYS A 4 -73.55 -47.83 REMARK 500 5 LYS A 17 49.15 -107.36 REMARK 500 5 ARG A 20 -79.36 -178.71 REMARK 500 5 CYS A 33 110.12 1.26 REMARK 500 6 TRP A 2 42.28 -147.80 REMARK 500 6 CYS A 4 -83.08 -37.58 REMARK 500 6 ILE A 15 136.88 170.68 REMARK 500 6 ARG A 20 -35.86 173.35 REMARK 500 6 MET A 21 166.33 161.87 REMARK 500 6 CYS A 33 -64.90 -14.68 REMARK 500 7 TRP A 2 14.83 -179.54 REMARK 500 7 ARG A 5 -37.98 -36.12 REMARK 500 7 ILE A 15 104.93 -56.98 REMARK 500 7 LYS A 17 29.84 -163.72 REMARK 500 7 ARG A 20 41.35 -169.52 REMARK 500 7 MET A 21 166.39 57.79 REMARK 500 7 CYS A 33 -165.37 21.26 REMARK 500 8 TRP A 2 38.47 -178.45 REMARK 500 8 CYS A 4 -80.44 -51.94 REMARK 500 8 LYS A 17 19.55 -152.40 REMARK 500 8 ARG A 20 -84.99 -177.49 REMARK 500 8 MET A 21 160.33 160.51 REMARK 500 8 LEU A 22 -51.02 179.64 REMARK 500 REMARK 500 THIS ENTRY HAS 100 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2A2H RELATED DB: PDB REMARK 900 THIS IS AN IDENTICAL PEPTIDE. THE STRUCTURE WAS DETERMINED IN HFIP. REMARK 900 RELATED ID: 1RG3 RELATED DB: PDB REMARK 900 THIS PEPTIDE CONSISTS OF THE C-TERMINAL HALF OF MINI-B. THE REMARK 900 STRUCTURE WAS DETERMINED IN SDS MICELLES. REMARK 900 RELATED ID: 1RG4 RELATED DB: PDB REMARK 900 THIS PEPTIDE CONSISTS OF THE C-TERMINAL HALF OF MINI-B. THE REMARK 900 STRUCTURE WAS DETERMINED IN HFIP. DBREF 2DWF A 1 18 UNP P07988 PSPB_HUMAN 208 225 DBREF 2DWF A 19 34 UNP P07988 PSPB_HUMAN 263 278 SEQRES 1 A 34 CYS TRP LEU CYS ARG ALA LEU ILE LYS ARG ILE GLN ALA SEQRES 2 A 34 MET ILE PRO LYS GLY GLY ARG MET LEU PRO GLN LEU VAL SEQRES 3 A 34 CYS ARG LEU VAL LEU ARG CYS SER HELIX 1 1 LEU A 3 ILE A 15 1 13 HELIX 2 2 PRO A 23 ARG A 32 1 10 SSBOND 1 CYS A 1 CYS A 33 1555 1555 2.04 SSBOND 2 CYS A 4 CYS A 27 1555 1555 2.03 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1